Perrigo Confirms First to File Patent Challenge for Generic Version of Testosterone Gel 1.62%Perrigo Co. (Nasdaq: PRGO) announced that it has filed with the U.S. Food and Drug Administration an Abbreviated New Drug Application for testosterone gel 1.62 percent and that it has notified AbbVie Inc., the owner of the Reference Listed Drug of its filing.
Perrigo Confirms FDA Approval For Testosterone Gel 1%Perrigo Company (Nasdaq: PRGO) announced that it has received U.S. Food and Drug Administration approval for its New Drug Application for testosterone gel 1%. Perrigo's NDA included a bioequivalence study that compared its product to AbbVie's AndroGel 1%.
Perrigo Confirms Filing For Testosterone Gel And Patent Infringement LawsuitAllegan's Perrigo confirms a regulatory finding for generic testosterone gel and a lawsuit by the company that makes the patented version.

More From CBS Detroit

Best Cooking Classes In DetroitLearn how to whip up some wonderful dishes while having fun!
5 Bucket List Items To Cross Off In DetroitThe “must-do” items for anyone making a trip to Detroit.
Best Spots For A Quick Lunch In Downtown DetroitThese places will get you in and out.

Watch & Listen LIVE